… its merger with GlaxoSmithKline Pharmaceuticals Limited. GSK Pharma stated that … operational activities. GSK Pharma added that it will … filing submitted by GlaxoSmithKline Pharmaceuticals Limited, the decree … Also Read: GlaxoSmithKline Pharma: Juby Chandy to …

We recently published 10 Firms in the Limelight. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best performers on Friday. BioMarin Pharmaceutical extended its winning streak to a third straight day on Friday, surging 17.71 percent to finish at $ …

We recently published 10 Firms in the Limelight. Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the best performers on Friday. Amicus Therapeutics soared to a new 52-week high on Friday, jumping 30.21 percent to close at $14.18 apiece as investors …

… may come in 2026. * * * Mega Mergers Reemerge. This year has witnessed … Bros., Teck Resources’ $69 billion merger of equals with Anglo American … the prevalence of CVRs in pharmaceutical and biotech M&A …

… a rebound in the merger and acquisition activity,” Lyons … 2024,” the report stated. Mergers and acquisitions aren’t … become a growing aspect of pharma’s commercialization strategies.  Pfizer … out the middlemen, including pharmacy benefit managers, Lyons said. …

A startup investment firm that specializes in short selling is accusing diagnostic imaging center operator RadNet Inc. of exaggerating its success. Others, meanwhile, are defending the Los Angeles-based radiology and AI company’s accounting practices.  …

… 28-year history. In a merger of rare disease specialists, BioMarin … soon face competition from Ascendis Pharma';s TransCon CNP, which … of the year after the drugmaker gained Inozyme for $270 million …

… clinical hold comes as the pharma partners said they were aiming … Alzheimer's med Fosun Pharma is spending about $200 million … 53% stake in Green Valley Pharmaceuticals, aiming to revive the latter … to go public in reverse merger with Vyne (release) 12. …

… regarding a proposed reverse merger transaction pursuant to which … testing solutions. CDL Pharma provides clinical trial logistics … obligations of the post-merger entity. Transaction Status … including ABL Diagnostics, CDL Pharma, and Humedics, delivering …

… regarding a proposed reverse merger transaction pursuant to which … Following completion of the merger, a newly established U … testing solutions. - CDL Pharma provides clinical trial logistics … obligations of the post-merger entity. Transaction Status The …